益方生物亮相科创板，手握3款核心“药方”，对外授权产品有望今年获批上市 - Sina
7/25/2022 12:00:00 AM2 years 9 months ago
by 21世纪经济报道
by 21世纪经济报道
益方生物亮相科创板，手握3款核心“药方”，对外授权产品有望今年获批上市
A 2022725Yaolin WangYueheng JiangXing Dai20D-0120D-0502D-1553IIIII EGFRBPI-D031620213NDACDE2022 31 IPO 403IIIII1NDA2022 3D-01201URAT1IIXOIURAT1 D-0120 D-0502SERD202110CDEIIISERDSERD Fulvestrant… [+332 chars]
full article...